The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Congestive Heart Failure After Treatment for Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group
Abstract
PURPOSE: We determined the frequency of and risk factors for congestive heart failure following treatment for Wilms’ tumor that included doxorubicin. PATIENTS AND METHODS: Flow sheets and medical records were reviewed to identify cases of congestive heart failure in a cohort of patients treated on National Wilms’ Tumor Studies (NWTS)-1, -2, -3, and -4. The frequency of congestive heart failure was estimated using the Kaplan-Meier method. A case-control study was conducted to determine the relationship among cumulative doxorubicin dose, site(s), total dose of abdominal and thoracic irradiation, sex, and the frequency of congestive heart failure. RESULTS: The cumulative frequency of congestive heart failure was 4.4% at 20 years after diagnosis among patients treated initially with doxorubicin and 17.4% at 20 years after diagnosis among those treated with doxorubicin for their first or subsequent relapse of Wilms’ tumor. The relative risk (RR) of congestive heart failure was increased in females (RR = 4.5; P = .004) and by cumulative doxorubicin dose (RR = 3.3/100 mg/m 2; P < .001), lung irradiation (RR = 1.6/10 Gy; P = .037), and left abdominal irradiation (RR = 1.8/10 Gy; P = .013). CONCLUSION: We conclude that congestive heart failure is a risk of treatment with doxorubicin for Wilms’ tumor. Additional follow-up of those children treated on NWTS-4 will be necessary to determine if the decrease in dose to 150 mg/m 2 significantly reduces this risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
Lipshultz, S. E., Colan, S. D., Gelber, R. D., Perez-Atayde, A. R., Sallan, S. E., & Sanders, S. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241205 · Cited by 1,404
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Lipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., & Colan, S. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322602 · Cited by 803
Treatment of Wilms' tumor. Results of the third national Wilms' tumor study
D'angio, G. J., Breslow, N., Beckwith, J. B., Evans, A., Baum, E., Delorimier, A., Fernbach, D., Hrabovsky, E., Jones, B., Kelalis, P., et al. (1989) · Cancer · doi:10.1002/1097-0142(19890715)64:2<349::aid-cncr2820640202>3.0.co;2-q · Cited by 681
Self-citationKrischer, J. P., Epstein, S., Cuthbertson, D. D., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1544 · Cited by 476
Triceps skin fold and upper arm muscle size norms for assessment of nutritional status
Frisancho, A. R. (1974) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/27.10.1052 · Cited by 459
The treatment of Wilms' tumor. Results of the national Wilms' tumor study
D'Angio, G. J., Evans, A. E., Breslow, N., Beckwith, B., Bishop, H., Feigl, P., Goodwin, W., Leape, L. L., Sinks, L. F., Sutow, W., et al. (1976) · Cancer · doi:10.1002/1097-0142(197608)38:2<633::aid-cncr2820380203>3.0.co;2-s · Cited by 457
Self-citationThe treatment of Wilms' Tumor: Results of the second national Wilms' Tumor study
D'Angio, G. J., Evans, A., Breslow, N., Beckwith, B., Bishop, H., Farewell, V., Goodwin, W., Leape, L., Palmer, N., Sinks, L., et al. (1981) · Cancer · doi:10.1002/1097-0142(19810501)47:9<2302::aid-cncr2820470933>3.0.co;2-k · Cited by 454
Self-citationCardiac disease following treatment of Hodgkin's disease in children and adolescents.
Hancock, S. L., Donaldson, S. S., & Hoppe, R. T. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1208 · Cited by 443
Steinherz, L. J., Graham, T., Hurwitz, R., Sondheimer, H. M., Schwartz, R. G., Shaffer, E. M., Sandor, G., Benson, L., & Williams, R. (1992) · Pediatrics · doi:10.1542/peds.89.5.942 · Cited by 327
Green, D. M., Breslow, N. E., Beckwith, J. B., Finklestein, J. Z., Grundy, P. E., Thomas, P. R., Kim, T., Shochat, S. J., Haase, G. M., Ritchey, M. L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.237 · Cited by 307
Self-citationCardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.
Shapiro, C. L., Hardenbergh, P. H., Gelman, R., Blanks, D., Hauptman, P., Recht, A., Hayes, D. F., Harris, J., & Henderson, I. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3493 · Cited by 264
Doxorubicin clearance in the obese.
Rodvold, K. A., Rushing, D. A., & Tewksbury, D. A. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.8.1321 · Cited by 213
Risk set sampling in epidemiologic cohort studies
Goldstein, L., & Langholz, B. (1996) · Statistical Science · doi:10.1214/ss/1032209663 · Cited by 197
Grundy, P. E., Breslow, N. E., Green, D. M., SHARPLES, K. J., Evans, A. E., & D’Angio, G. J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.638 · Cited by 185
Self-citationGreen, D. M., Breslow, N. E., Beckwith, J. B., Finklestein, J. Z., Grundy, P., Thomas, P. R., Kim, T., Shochat, S., Haase, G., Ritchey, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.12.3744 · Cited by 169
Self-citationGoorin, A. M., Chauvenet, A. R., Perez-Atayde, A. R., Cruz, J., McKone, R., & Lipshultz, S. E. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81668-3 · Cited by 163
Sorensen, K., Levitt, G., Bull, C., Chessells, J., & Sullivan, I. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.61 · Cited by 160
Increased risk of cardiac dysfunction after anthracyclines in girls
Silber, J. H., Jakacki, R. I., Larsen, R. L., Goldwein, J. W., & Barber, G. (1993) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950210704 · Cited by 151
Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry
Dobbs, N. A., Twelves, C. J., Gillies, H., James, C. A., Harper, P., & Rubens, R. D. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685796 · Cited by 117
Cardiac function in Wilms' tumor survivors.
Sørensen, K. E., Levitt, G., Sebag‐Montefiore, D., Bull, C., & Sullivan, I. D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1546 · Cited by 95
Gulati, S. C., Sordillo, P. P., Kempin, S. J., REICH, L. M., Magill, G. B., Scheiner, E., & Clarkson, B. D. (1980) · Cancer · doi:10.1002/1097-0142(19800501)45:9<2231::aid-cncr2820450902>3.0.co;2-3 · Cited by 72
Nonparametric Estimation of Relative Mortality from Nested Case-Control Studies
Borgan, Ø., & Langholz, B. M. (1993) · Biometrics · doi:10.2307/2532571 · Cited by 54
Adriamycin cardiotoxicity in children.Case reports, literature review, and risk factors
Prout, M. N., Richards, M. J. S., Chung, K. J., Joo, P., & Davis, H. L. (1977) · Cancer · Cited by 52
Cardiac dysfunction late after cardiotoxic therapy for childhood cancer
Leandro, J., Dyck, J. D., Poppe, D., Shore, R. M., Airhart, C., Greenberg, M., Gilday, D. L., Smallhorn, J. F., & Benson, L. N. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90470-7 · Cited by 47
Johnson, G. L., Moffett, C. B., Geil, J. D., Greenwood, M. F., & Noonan, J. A. (1996) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199602000-00014 · Cited by 29
Cited by
Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564
Mulrooney, D. A., Yeazel, M. W., Kawashima, T., Mertens, A. C., Mitby, P., Stovall, M., Donaldson, S. S., Green, D. M., Sklar, C. A., Robison, L. L., et al. (2009) · BMJ · doi:10.1136/bmj.b4606 · Cited by 1,166
Self-citationMedical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer
Geenen, M. M., Cardous-Ubbink, M. C., Kremer, L. C. M., van den Bos, C., van der Pal, H. J. H., Heinen, R. C., Jaspers, M. W. M., Koning, C. C. E., Oldenburger, F., Langeveld, N. E., et al. (2007) · JAMA · doi:10.1001/jama.297.24.2705 · Cited by 860
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Dalton, V. M., Mone, S. M., Gelber, R. D., & Colan, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.121 · Cited by 727
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035153 · Cited by 623
Metadata
- Authors
- Green, D. M., Grigoriev, Y. A., Nan, B., Takashima, J. R., Norkool, P. A., D’Angio, G. J., & Breslow, N. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-04-01
- Volume
- 19
- Issue
- 7
- Pages
- 1926-1934
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1913539970
- Cited by
- 319
- References
- 28
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.